Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland.

Barbara ScottiGiulio DisantoRosaria SaccoMarilu' GuigliChiara ZeccaClaudio Gobbi

Published in: PloS one (2018)

These results provide further evidence for RTX being effective in MS treatment, to a similar extent to natalizumab in RRMS. Clinicians must be vigilant for the potential occurrence of infections.

Keyphrases

multiple sclerosis
white matter
risk assessment
mass spectrometry
diffuse large b cell lymphoma
palliative care
ms ms
replacement therapy
combination therapy
chronic lymphocytic leukemia